Confidential Regeneration Program(s)
Not Specified (Likely neurodegeneration, tissue repair)
Pre-clinicalActive
Key Facts
Indication
Not Specified (Likely neurodegeneration, tissue repair)
Phase
Pre-clinical
Status
Active
Company
About Revivocell
Revivocell is a private, pre-clinical stage biotech firm headquartered in London, operating at the intersection of AI and regenerative medicine. Its core focus is a proprietary technology platform designed to discover and develop cell regeneration therapies, positioning it in the high-growth field of longevity and age-related diseases. While still pre-revenue, the company's approach targets a significant unmet medical need with potential applications across multiple therapeutic areas. Its success hinges on translating its AI-driven platform into clinically validated and commercially viable therapies.
View full company profile